Complement component5 (C5) is a protein in the complementcascadeand a part of the innate immune system that has been clinically validatedas a therapeutic target for several immune-mediated diseases includinggeneralized myasthenia gravis (gMG). This evidence concerns the gene C5 and myasthenia gravis.